💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Acura Pharmaceuticals, Inc. (ACUR)
« Back to company indexACUR Chatter Timeline
Stock Ticker for ACUR
Most Active Tweeters for ACUR
| User | Tweets |
|---|---|
| @FlashAlert_me | 8 |
| @Allstocknews | 1 |
| @aheadsupotc | 1 |
| @InsiderAlerts4U | 1 |
| @shortablestocks | 1 |
Recent Tweets for ACUR
 |
@shortablestocks Zero shares available to short currently in $ACUR. https://t.co/LLedUPaZhc January 14th 2021, 4:01pm |
 |
@InsiderAlerts4U $ACUR: New Insider Filing on ACURA PHARMACEUTICALS, INC's Director IMMANUEL THANGARAJ: https://t.co/AkYC6NrxWf January 12th 2021, 10:01pm |
 |
@aheadsupotc $ACUR new alert at https://t.co/knzARFId2i #Penny #pennystocks #PinkSheet #OTC #OTCBB #stocks 295 January 12th 2021, 9:01pm |
 |
@FlashAlert_me $ACUR [15s. delayed] filed SEC form 4: Director THANGARAJ IMMANUEL: Converted securities 54,790 of Common Stock at… https://t.co/8REaGT7JgX January 12th 2021, 9:01pm |
 |
@Allstocknews $ACUR New Form 4 for Acura Pharmaceuticals, Inc. From our Stock News Alerts App January 6th 2021, 4:01pm |
|
@FlashAlert_me $ACUR [15s. delayed] filed SEC form 4: Director ROSS GEORGE K: Converted securities 54,790 of Common Stock at pric… https://t.co/ZNItzdCRz9 January 6th 2021, 4:01pm |
|
@FlashAlert_me $ACUR [15s. delayed] filed SEC form 4: Director WESSON BRUCE F: Converted securities 54,790 of Common Stock at pri… https://t.co/uKR52eqGzA January 6th 2021, 4:01pm |
|
@FlashAlert_me $ACUR [15s. delayed] filed SEC form 4: Director SKELLY WILLIAM G: Converted securities 54,790 of Common Stock at p… https://t.co/Rjh7XVbuHp January 6th 2021, 4:01pm |
|
@FlashAlert_me $ACUR [15s. delayed] filed SEC form 4: VP, Corporate Development EMIGH JAMES F: Delivered securities 7,402 of Comm… https://t.co/KzaMdeAuBi January 6th 2021, 4:01pm |
|
@FlashAlert_me $ACUR [15s. delayed] filed SEC form 4: President & CEO Jones Robert B: Converted securities 63,667 of Common Stock… https://t.co/5DulEDecym January 6th 2021, 4:01pm |
|
@FlashAlert_me $ACUR [15s. delayed] filed SEC form 4: Senior VP & CFO CLEMENS PETER A: Delivered securities 19,514 of Common Stoc… https://t.co/NOODl3FJCr January 6th 2021, 4:01pm |
|
@FlashAlert_me $ACUR [15s. delayed] filed SEC form 4: VP, Pharmaceutical Sciences Brzeczko Albert W: Converted securities 43,334… https://t.co/vD7Qsuek1Z January 6th 2021, 4:01pm |
 |
@CSIMarket $ACUR #Stocks #StockMarket #AcuraPharmaceuticals released third quarter of 2020 EPS on https://t.co/savSNTKlN1: ACU… https://t.co/VHoGa9AXFx November 17th 2020, 6:11pm |
 |
@marketexclusive $ACUR ACURA PHARMACEUTICALS, INC. (NASDAQ:ACUR) Files An 8-K Results of Operations and Financial Condition https://t.co/gwaMLVXw26 November 17th 2020, 4:11pm |
|
@Allstocknews $ACUR New Form 8-K for Acura Pharmaceuticals, Inc. From our Stock News Alerts App November 17th 2020, 4:11pm |
|
@FlashAlert_me $ACUR [15s. delayed] filed form 8-K on November 17, 16:10:16: Item2.02: Results of Operations & Financial Condition https://t.co/MXBi5hJI3l November 17th 2020, 4:11pm |
 |
@EdgarInsider A new filing Form 8-K [Press/News Current Report] has been made at the SEC by $ACUR #AcuraPharmaceuticals, Inc https://t.co/HammaGQhuv November 17th 2020, 4:11pm |
|
@EdgarInsider A Form 10-Q [Quarterly Report] filing has been made with the SEC: $ACUR #AcuraPharmaceuticals, Inc https://t.co/LwHHPhYrQc November 16th 2020, 6:11pm |
 |
@MarcJacksonLA $ACUR Acura Pharmaceuticals Announces Third Quarter 2020 Financial Results https://t.co/t6yEn2TbIH November 16th 2020, 5:11pm |
 |
@jodietheai 5 section(s) of $ACUR 10-Q analyzed; J? score of 8.2/10, 3.45% difference since last filing. 4 redflags found in… https://t.co/bXs4QxB3Vs November 16th 2020, 4:11pm |
 |
@otc_watch_news $ACUR #OTCQB Acura Pharmaceuticals, Inc. (ACUR: OTCQB) | Acura Pharmaceuticals Announces Third Quarter 2020 Financi… https://t.co/cDsm1ofobg November 16th 2020, 4:11pm |
|
@Allstocknews $ACUR New Form 10-Q for Acura Pharmaceuticals, Inc. From our Stock News Alerts App November 16th 2020, 4:11pm |
|
@Allstocknews $ACUR Acura Pharmaceuticals Announces Third Quarter 2020 Financial Results From our Stock News Alerts App November 16th 2020, 4:11pm |
|
@FlashAlert_me $ACUR [15s. delayed] filed form 8-K on October 29, 16:10:17: Item1.01: Entry into a Material Definitive Agreement https://t.co/uNAmXxwzLi October 29th 2020, 4:10pm |
|
@MarcJacksonLA $ACUR Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03 Amendment Extends NDA Acceptance Date and… https://t.co/a4NhoGV6CW October 28th 2020, 9:10pm |
|
@otc_watch_news $ACUR #OTCQB Acura Pharmaceuticals, Inc. (ACUR: OTCQB) | Acura Pharmaceuticals and AD Pharma Amend License to LIMIT… https://t.co/7ZOo9NkZuQ October 28th 2020, 4:10pm |
|
@Allstocknews $ACUR Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03 From our Stock News Alerts App October 28th 2020, 4:10pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
